经过急性中脑损伤后,延迟的勒沃多巴反应性帕金森症
Tali Friedman-Korn1, Caroline Weill1, Simona Ben-Haim2
1Department of Neurology, Hadassah Medical Center and the Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
Journal of the neurological sciences
|April 4, 2024
概括
在急性中脑损伤后延迟的帕金森症是罕见的,但应该得到认可. 三名男性患者在中脑损伤多年后发展出了对利沃多巴敏感的帕金森症,表现为条形状吸收减少.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 运动障碍 运动障碍
背景情况:
- 急性中脑损伤可能导致高动力运动障碍或帕金森症.
- 在中脑损伤后,帕金森症的延迟发病很少被报告.
研究的目的:
- 描述急性中脑损伤后延迟,对levodopa反应的帕金森病的病例.
- 强调在临床实践中认识到这种情况的重要性.
主要方法:
- 三名中脑损伤的男性患者的病例系列.
- 临床评估,包括对levodopa的反应.
- 罗多巴扫描以评估两名患者的条形状吸收.
主要成果:
- 患者在中脑损伤后的2,8年和20年内发展出帕金森症.
- 侮辱包括出血,栓塞和创伤.
- 所有患者都在服用莱沃多巴后表现好转,并出现运动波动.
结论:
- 在中脑损伤后,可以出现延迟的,对利沃多巴敏感的帕金森症.
- 潜在的机制包括叠加的与年龄相关的多巴胺基损失和二次神经退行.
- 这种情况需要在相关的临床环境中得到认可.
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541


